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ABSTRACT
Bovine herpesvirus-1 (BoHV-1) is a viral pathogen 
of global significance that is known to instigate several 
diseases in cattle, the most notable of which include 
infectious bovine rhinotracheitis and bovine respiratory 
disease. The genetic variability in the humoral im-
mune response to BoHV-1 has, to our knowledge, not 
ever been quantified. Therefore, the objectives of the 
present study were to estimate the genetic parameters 
for the humoral immune response to BoHV-1 in Irish 
female dairy cattle, as well as to investigate the genetic 
relationship between the humoral immune response to 
BoHV-1 with milk production performance, fertility 
performance, and animal mortality. Information on an-
tibody response to BoHV-1 was available to the present 
study from 2 BoHV-1 sero-prevalence research studies 
conducted between the years 2010 to 2015, inclusive; 
after edits, BoHV-1 antibody test results were available 
on a total of 7,501 female cattle from 58 dairy herds. 
National records of milk production (i.e., 305-d milk 
yield, fat yield, protein yield, and somatic cell score; n 
= 1,211,905 milk-recorded cows), fertility performance 
(i.e., calving performance, pregnancy diagnosis, and 
insemination data; n = 2,365,657 cows) together with 
animal mortality data (i.e., birth, farm movement, 
death, slaughter, and export events; n = 12,853,257 
animals) were also available. Animal linear mixed 
models were used to quantify variance components 
for BoHV-1 as well as to estimate genetic correlations 
among traits. The estimated genetic parameters for the 
humoral immune response to BoHV-1 in the present 
study (i.e., heritability range: 0.09 to 0.16) were simi-
lar to estimates previously reported for clinical signs 
of bovine respiratory disease in dairy and beef cattle 
(i.e., heritability range: 0.05 to 0.11). Results from the 
present study suggest that breeding for resistance to 
BoHV-1 infection could reduce the incidence of respira-
tory disease in cattle while having little or no effect 
on genetic selection for milk yield or milk constituents 
(i.e., genetic correlations ranged from −0.13 to 0.17). 
Moreover, even though standard errors were large, re-
sults also suggest that breeding for resistance to BoHV-
1 infection may indirectly improve fertility performance 
while also reducing the incidence of mortality in older 
animals (i.e., animals >182 d of age). Results can be 
used to inform breeding programs of potential genetic 
gains achievable for resistance to BoHV-1 infection in 
cattle.
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INTRODUCTION
Infectious bovine rhinotracheitis (IBR) is a conta-
gious viral respiratory disease of cattle caused by infec-
tion with bovine herpesvirus-1 (BoHV-1). Listed as a 
notifiable disease by the World Organization for Ani-
mal Health, IBR is of global importance and may even 
be considered a disease of trade, especially within the 
European Union (EU). Several countries and regions 
have achieved an IBR-free status according to Article 
10 of EU Council Directive 64/432/EEC, whereas oth-
ers have approved eradication programs according to 
Article 9 of the same Directive. In both cases, Commis-
sion 2007/584/EC grants them additional guarantees 
with respect to trade with other member states of the 
EU. Furthermore, Council Directive 2003/43/EC pro-
hibits the entry of bulls with BoHV-1 antibodies to 
bovine semen collecting centers in member states or 
third countries where semen is collected for intra-com-
munity trade or import to the EU. Cowley et al. (2011) 
reported that 74.9% of Irish dairy and beef herds were 
sero-positive for BoHV-1. Although no national IBR 
control or eradication program currently exists in Ire-
land, Animal Health Ireland (www .animalhealthireland 
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.ie) is currently developing the technical and business 
case for such a program.
Clinical signs of IBR in cattle include reduced appe-
tite (Muylkens et al., 2007), elevated body temperature 
(Thompson et al., 1965; Muylkens et al., 2007), con-
junctivitis and inflammation of the nares and trachea 
(Thompson et al., 1965), reduced milk production 
(Hage et al., 1998), compromised reproductive perfor-
mance (Graham, 2013), and death (AFBI and DAFM, 
2016). Bovine herpesvirus-1 infected animals are also 
predisposed to secondary infections (Yates, 1982). The 
severity of clinical signs arising from BoHV-1 infec-
tion vary depending upon the immune status of the 
animal (Muylkens et al., 2007) and the virulence of 
the BoHV-1 strain (Kaashoek et al., 1996). Infection 
with BoHV-1 for the very first time (i.e., primary infec-
tion) typically results in clinical signs and the shedding 
of BoHV-1 (Engels and Ackermann, 1996). Following 
primary infection, animals become latently infected, 
no longer exhibiting clinical signs, synthesizing or 
shedding BoHV-1 (Engels and Ackermann, 1996), but 
continuing to harbor the virus in their nervous system 
(Muylkens et al., 2007). These latently infected animals 
have the potential to reactivate and re-excrete BoHV-1 
(Geraghty et al., 2012), generating new primary infec-
tions during periods of stress, corticosteroid treatment, 
or when re-exposed to circulating BoHV-1. Latently 
infected animals are lifelong carriers of BoHV-1 and 
potential transmitters of the virus between herds. 
Transmission of BoHV-1 can also occur by airborne 
spread, use of semen from infected bulls, or through the 
use of contaminated equipment or clothing.
To our knowledge, no study has attempted to quan-
tify the genetic variability in the humoral immune re-
sponse to BoHV-1 in dairy cattle or its association with 
performance. However, evidence of genetic variability 
in the prevalence of clinical signs to other viral dis-
eases in cattle does exist. Muggli-Cockett et al. (1992) 
identified breed differences among 9 purebred and 3 
composite beef breeds in clinical signs of bovine respi-
ratory disease (BRD) with Braunvieh and Pinzgauer 
breeds exhibiting a greater prevalence of BRD than the 
other purebred and composite breeds. Heringstad et al. 
(2008) also reported a heritability estimate for BRD of 
0.05 in a population of Norwegian Red calves, although 
in that study BRD was unlikely to have been caused 
by BoHV-1 because the Norwegian cattle population is 
deemed free of IBR (Heringstad et al., 2008).
The objective of the present study was to quantify 
the genetic variation present among Irish dairy cattle 
females in their humoral immune response to BoHV-1 
and the genetic association of humoral immune re-
sponse to BoHV-1 with milk and fertility performance 
traits as well as animal mortality. Results can be used 
to determine the feasibility of genetic selection in cattle 
for enhanced resistance to BoHV-1 through either se-
lection for resistant breeding animals or exclusion of 
susceptible animals from breeding stock. Furthermore, 
results can be used to determine if current breeding 
goals for performance traits may be influencing the 
humoral immune response to BoHV-1.
MATERIALS AND METHODS
Data
The BoHV-1 data originated from 2 Irish sero-preva-
lence studies undertaken by the Animal and Grassland 
Research and Innovation Centre, Teagasc, Moorepark, 
Fermoy, Co. Cork, Ireland, between the years 2010 and 
2015, inclusive. National records of milk production 
performance and fertility performance were also avail-
able from the Irish Cattle Breeding Federation (ICBF) 
database for the years 2010 to 2015, inclusive. Further-
more, national animal mortality records were available 
from the ICBF database for animals that were born 
between the years 2001 and 2015, inclusive.
BoHV-1 Data
One BoHV-1 data set originated from a sero-
prevalence study of BoHV-1 conducted between 
October 2010 and February 2013, which consisted of 
6,534 female cattle from 24 dairy herds. Herds that 
participated in the study were Teagasc research farms 
or participants in the Dairy Management Information 
System, a system that collates producer-recorded stock, 
farm inputs, production, and reproduction information 
(Crosse, 1991). The average number of cows per herd 
over the study period was 193, ranging from 71 to 758 
cows. Holstein, Jersey, Norwegian Red, and Friesian 
were the main breeds, accounting for 96% of animals. 
Blood samples were collected from each animal at least 
once during the 4-yr period and tested for the presence 
of BoHV-1 antibodies. Each herd’s vaccination history 
for each year was also collected. The only information 
available pertaining to herd-level vaccination status 
was whether the herd was either not vaccinating or 
vaccinating with a marker vaccine; information on the 
frequency of vaccination or the type of vaccination 
used (i.e., live or inactivated vaccine) was not available. 
Herd-level vaccination status was used to interpret the 
test kit used for detecting animal-level BoHV-1 anti-
bodies. Currently, 2 types of test kits are available to 
detect BoHV-1 antibodies (i.e., gB and gE test kits). 
Marker vaccines, non-marker vaccines, and field virus 
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each cause the production of antibodies to the gly-
coprotein B of BoHV-1 virus; therefore, gB antibody 
tests detect BoHV-1 antibodies derived from marker 
vaccines, non-marker vaccines, or field virus. On the 
other hand, only non-marker vaccines and field virus 
cause the production of antibodies to glycoprotein E 
of BoHV-1 virus; marker vaccines do not contain gly-
coprotein E and thus they do not cause the production 
of antibodies to the glycoprotein E of BoHV-1 virus; 
therefore, gE antibody tests detect BoHV-1 antibodies 
derived only from non-marker vaccines or field virus 
(World Organisation for Animal Health, 2010). As the 
only type of vaccine licensed in the Republic of Ireland 
is the marker vaccine (S.I. No. 528 of 2002), animals 
with BoHV-1 antibodies in vaccinated herds (n = 13 
herds) were detected using a gE test kit; animals with 
BoHV-1 antibodies in nonvaccinated herds (n = 11 
herds) were detected using a gB test kit. All antibody 
testing was performed on individual blood samples 
at Enfer Diagnostics (Newhall, Naas, Co. Kildare, 
Ireland) using an IDEXX ELISA test kit (www .idexx 
.com), appropriate for the vaccination status of each 
herd. Fifty-two percent of all samples were analyzed 
using the gE test kit. Sample-to-positive (S/P) ratio 
was used to classify test results as positive, negative, 
or inconclusive; the cut-off thresholds used to classify 
tests results as positive, negative, or inconclusive were 
in accordance with the manufacturer’s guidelines for 
each respective test. For vaccinated animals, a positive 
antibody response was identified by an S/P ratio ≤0.60, 
whereas a negative antibody response was identified by 
an S/P ratio ≥0.70; an inconclusive antibody response 
was identified by an S/P ratio that was intermediate to 
a positive antibody response and a negative antibody 
response. For nonvaccinated animals, a positive anti-
body response was identified by an S/P ratio ≥0.55, 
whereas a negative antibody response was identified by 
an S/P ratio ≤0.50; an inconclusive antibody response 
was identified by an S/P ratio that was intermediate 
to a positive antibody response and a negative anti-
body response. Inconclusive test results (n = 16) were 
removed from the data set. When gE and gB test kit 
results were combined, the overall apparent prevalence 
of BoHV-1 antibody positive animals in the data set 
was 26%.
The second data set originated from a separate field 
trial carried out on 10,669 cows from 67 dairy herds 
during the 2015 calendar year. The aim of this trial 
was to collect accurate phenotypic health and perfor-
mance data from a large sample of the national dairy 
cow population. Each participating herd was a member 
of HerdPlus, a breeding information service provided 
by ICBF, and had a history of accurate and timely 
performance recording. For logistical reasons, the par-
ticipating herds were located within a 1-h drive from 
Moorepark Research Centre. The average herd size was 
157 cows, ranging from 39 to 527 cows. Holstein, Jersey, 
and Friesian were the main breeds, accounting for 97% 
of the cows. Throughout the trial, producers recorded 
all cow-related diseases and treatments on the ICBF 
database. Each herd’s vaccination history for that year 
was collected as part of a survey and later verified. 
The only information available pertaining to herd-level 
vaccination status was whether the herd was either not 
vaccinating or vaccinating with a marker vaccine; in-
formation on the frequency of vaccination and the type 
of vaccination used (i.e., live or inactivated vaccine) 
was not available. Blood samples were collected from 
each cow in the autumn of 2015 and analyzed for the 
presence of BoHV-1 antibodies. The BoHV-1 antibody 
testing, appropriate for the vaccination status of each 
herd (i.e., 55 herds were vaccinating, whereas 12 herds 
were not vaccinating), was carried out on individual 
blood samples using either an IDVet gE ELISA (www 
.id -vet .com) or a Qiagen gB ELISA (www .qiagen .com) 
test kit at FarmLab Diagnostics (Emlagh, Elphin, Co. 
Roscommon, Ireland). Eighty-six percent of tests were 
undertaken using the gE test kit. Sample-to-positive 
ratio was used to classify test results as positive or 
negative; the cut-off thresholds used to classify tests 
results as positive, negative, or inconclusive were in ac-
cordance with the manufacturer’s guidelines for each 
respective test. For vaccinated animals, a positive an-
tibody response was identified by an S/P ratio ≤0.40, 
whereas a negative antibody response was identified by 
an S/P ratio ≥0.50; an inconclusive antibody response 
was identified by an S/P ratio that was intermediate to 
a positive antibody response and a negative antibody 
response. For nonvaccinated animals, a positive anti-
body response was identified by an S/P ratio ≥0.55, 
whereas a negative antibody response was identified by 
an S/P ratio ≤0.45; an inconclusive antibody response 
was identified by an S/P ratio that was intermediate to 
a positive antibody response and a negative antibody 
response. Inconclusive test results (n = 101) were re-
moved from the data set. When gE and gB test kit re-
sults were combined, the overall apparent prevalence of 
cows that had a positive antibody response to BoHV-1 
in the data set was 23%.
After combining both data sets, 19,353 BoHV-1 
antibody test results were available on 16,242 female 
cattle from 81 dairy herds. As well as considering di-
chotomized BoHV-1 traits (i.e., positive or negative), 
continuous BoHV-1 traits were also considered further 
(i.e., S/P ratio for animals considered positive or nega-
tive based on the binary trait). To facilitate a combined 
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analysis of tests carried out using gE test kits from 
different manufacturers (i.e., IDEXX or IDVet, where 
the dependent variable was the continuous trait), test 
results were standardized to a common variance and a 
mean of zero [i.e., (test value − mean test value of the 
respective test kit manufacturer) ÷ standard deviation 
of test values for the respective test kit manufacturer]. 
Similarly, test results from samples carried out using 
gB test kits from different manufacturers (i.e., IDEXX 
or Qiagen) were also standardized; test results carried 
out using differing test kits (i.e., gE or gB) were not 
standardized to a common variance or a mean of zero.
BoHV-1 Edits
Test results for animals sired by a beef breed (n = 
166) and nulliparous animals that were either less than 
182 d of age (n = 1) or more than 908 d of age (n 
= 158) on the date of blood sample collection were 
discarded. As a comprehensive history of herd vaccina-
tion status was not available for older cows, BoHV-1 
test results from ≥6th parity cows (n = 1,788) were 
also removed. Furthermore, test results from cows that 
calved less than 545 d of age (n = 4) were removed as 
were test results from cows that calved more than 545 
d from the parity median (n = 68) or cows that did 
not calve within 545 d of the date of blood sample col-
lection (n = 219). To maximize the likelihood of equal 
lifetime exposure to BoHV-1, only animals born in the 
herd that they were blood sampled in were retained; 
15,019 test results from 12,823 animals in 81 herds re-
mained. Moreover, only the most recent test result for 
animals deemed exposed to BoHV-1 (described herein) 
was considered further; a total of 7,501 animals from 58 
herds remained.
BoHV-1 Exposure Definitions
In Irish dairy herds, nulliparous females (i.e., females 
≤30 mo without a calving event) are typically managed 
separately from cows (i.e., females with ≥1 calving 
event); as a result, exposure to BoHV-1 was defined in 
each herd-management group separately. Exposure to 
BoHV-1 was defined in 2 ways: the first, a relaxed defi-
nition, considered a herd’s vaccination status, and the 
second definition, a strict definition, did not consider a 
herd’s vaccination status.
Relaxed Definition. An animal in a nonvaccinated 
herd-management group was deemed exposed where 
that animal was tested for BoHV-1 antibodies in the 
same year as at least one animal that returned a positive 
BoHV-1 test result, irrespective of that animal’s age. 
An animal in a vaccinated herd-management group was 
deemed exposed where that animal was either older 
or born in the same year as at least one animal that 
returned a positive BoHV-1 test result, provided both 
animals were tested for BoHV-1 antibodies in the same 
year.
Strict Definition. An animal that was both born 
and tested for BoHV-1 antibodies in the same year as 
at least one animal that returned a positive BoHV-1 
test result was deemed exposed; this definition applied 
to both animals in vaccinated and nonvaccinated herds.
Milk Production Performance Data
Milk production performance data were available 
for the years 2010 and 2015, inclusive for 2,647,818 
lactations from 1,211,905 milk-recorded cows in 10,421 
dairy herds; milk performance traits included 305-d 
milk yield, fat yield, protein yield, and SCC divided 
by 1,000 for cows in their first to fifth parity, inclu-
sive. Fat concentration, protein concentration, and 
fat-to-protein ratio were calculated from the available 
data. Somatic cell score was derived from the natural 
logarithm of SCC after dividing by 1,000. Lactations 
with any milk performance trait missing or deviating 
>3 standard deviation units from the parity mean (n 
= 108,990 lactations) were discarded as were lactations 
from cows that produced twins (n = 41,552 lactations) 
or lactations that began fewer than 300 d following a 
cow’s most recent calving (n = 17,585 lactations). In 
addition, lactations from cows that calved <545 d of 
age (n = 1,523 lactations) or >545 d from the parity 
median (n = 67,092 lactations) were discarded. More-
over, lactations from cows that did not reside in their 
birth herd were also removed; 286,374 lactations from 
152,230 cows in 7,327 herds were removed. A total of 
2,124,836 lactations from 1,017,009 cows in 9,028 herds 
remained.
Fertility Performance Data
Calving performance (n = 5,699,148), pregnancy 
diagnoses (n = 1,254,358), together with natural ser-
vice and AI data (n = 4,257,607), were available for 
2,365,657 cows in 18,069 dairy herds for the years 2010 
to 2015, inclusive. Where possible, 11 fertility perfor-
mance traits were derived for each cow-parity separately 
for cows in their first to fifth parity, inclusive. Prior to 
trait definition, where 2 services occurred within 5 d of 
each other, the initial service was discarded. Fertility 
performance records from cows that calved <545 d of 
age (n = 1,586 records) or >545 d from the parity 
median (n = 266,567 records) were discarded. In ad-
dition, cow parities that resulted in twin progeny (n 
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= 79,244) were removed as were fertility performance 
records from cows that did not reside in their birth 
herd (n = 775,174 records).
Fertility Performance Trait Definition
Fertility performance traits considered in the present 
study were described in detail by Berry et al. (2013). 
The traits considered were age at first calving (AFC), 
calved during the initial 42 d of a herd’s calving season 
(CALV42), calving interval (CIV), calving to first 
service interval (CFS), submission rate in the initial 
21 d of a herd’s breeding season (SR21), number of 
services (NSV), calving to conception interval (CCI), 
first service to conception interval (FSC), pregnant to 
first service (PRFS), pregnant during the initial 21 
d of a herd’s breeding season (PR42), and survival 
(SURV). The 11 fertility traits are described in the 
present study under 4 broad sections that include (1) 
calving, (2) breeding, (3) conception, and (4) survival.
Calving. Age at first calving was defined as the age, 
in days, when a female first calved; cows that calved 
for the first time >1,240 d of age (n = 4,993 cows) 
were not considered for AFC. As Irish herds typically 
endeavor to achieve compact calving systems, calving 
seasons were defined separately for each herd to cap-
ture the distinct periods in a herd where many cows 
calve in close proximity to each other. A herd’s calv-
ing season was defined for nulliparous and pluriparous 
animals separately using methods described by Berry 
et al. (2013). The onset of a calving season was trig-
gered by a calving event that was followed by at least 4 
subsequent calvings occurring within 14 d of the initial 
calving. The calving season concluded when a calving 
event was not followed by a subsequent calving in the 
following 21 d. Only calving seasons with at least 5 nul-
liparous animals or at least 20 multiparous cows were 
considered where the calving period was 35 to 200 d 
in length. The trait CALV42 was defined as whether a 
cow calved (CALV42 = 1) or did not calve (CALV42 = 
0) within the initial 42 d of a herd’s calving season; a 
cow that did not calve within a calving season was not 
considered for CALV42. Calving interval was defined as 
the number of days between consecutive calving events; 
where a cow was serviced within 150 d of calving, CIV 
records between 300 and 800 d, inclusive, were consid-
ered, and otherwise CIV records ranging from 300 to 
600 d were considered.
Breeding. Calving to first service interval was cal-
culated as the number of days between a cow’s calving 
and her first service event (either AI or natural service); 
only CFS records between 10 and 250 d, inclusive, were 
retained. To achieve compact calving systems, produc-
ers must operate a compact breeding system. Thus, 
breeding seasons were defined using a similar method-
ology to calving seasons; breeding seasons were defined 
for primiparous and multiparous animals combined. A 
breeding season began when 5 cows were serviced within 
14 d of an initial service. A breeding season terminated 
when a service was not followed by a subsequent service 
in the following 21 d. Only breeding seasons between 
35 and 140 d in length were considered where there 
were more than 20 cows per breeding season. Submis-
sion rate in the initial 21 d of a herd’s breeding season 
was defined as whether a cow was serviced for the first 
time (SR21 = 1) or was not serviced for the first time 
(SR21 = 0) in the initial 21 d of a herd’s breeding 
season, irrespective of her calving date; a cow that was 
serviced for the first time either before or after a breed-
ing season was not considered for SR21. Number of 
services was defined as the total number of services 
a cow received per parity; where a cow received more 
than 10 services, NSV was fixed to 10. To eliminate 
herds that typically record only a cow’s final service, 
all fertility performance records were discarded from 
herd-years that documented only one service for >80% 
of cows; 855,793 fertility records from 8,665 herds were 
removed.
Conception. The day a cow conceived was assumed 
as her final service date where the number of days be-
tween her final service and her subsequent calving was 
between 268 and 298 d, inclusive. Where a subsequent 
calving date was not available, a cow was assumed to 
conceive on her final service date provided a viable 
pregnancy was detected at scanning and a service did 
not follow that scan.
Where a conception date was available, CCI was 
defined as the number of days between calving and 
conception; only CCI records ranging from 10 to 350 d, 
inclusive, were considered. First service to conception 
interval was defined as the number of days between a 
cow’s first service and conception; only FSC intervals 
up to 350 d were retained. Cows considered to have 
conceived on the day they were first serviced were as-
sumed pregnant to first service (PRFS = 1); otherwise, 
cows that subsequently calved more than 313 d after 
their first service together with cows scanned without a 
viable pregnancy after their first service were assumed 
not pregnant to first service (PRFS = 0). Irrespective 
of calving date, a cow was assumed pregnant if she con-
ceived in the initial 42 d of a predefined breeding season 
(PR42 = 1); a cow serviced in the initial 42 d of a 
breeding season that did not subsequently calve within 
313 d of that service together with any cow scanned 
without a viable pregnancy >42 d after the start of a 
breeding season was assumed not pregnant within 42 d 
of the breeding season (PR42 = 0).
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Survival. A cow was assumed to have survived par-
ity i if she reached parity i + 1 (SURV = 1); a cow that 
did not reach parity i + 1 was assumed not to have 
survived parity i (SURV = 0), provided the cow either 
died or was slaughtered within 400 d of calving or the 
difference between the cow’s most recent test-day milk 
record was more than 140 d from the herd’s most re-
cent test-day milk record. Cows that did not meet the 
aforementioned criteria were not considered for SURV.
Mortality Data
Since the implementation of Statutory Instrument 
No. 655/2003, cattle producers in the Republic of Ire-
land are legally required to inform the Department of 
Agriculture, Food and the Marine of each animal birth, 
calving, farm movement, death, slaughter and export 
events. These data were extracted from the ICBF data-
base for all animals born between January 1, 2001, and 
December 31, 2015. Only singletons born to dams aged 
between 545 and 3,650 d at calving were considered, as 
were cow parities that resulted in singletons; the data 
set consisted of 12,853,257 animals in 121,588 dairy 
herds. Animals that did not reside in their birth herd 
(n = 180,436 animals) were not considered further. 
Primiparous lactations from cows that calved <545 d 
of age (n = 2,665 cows) or >1,240 d of age (n = 30,754 
cows) were discarded as were pluriparous cow lacta-
tions from cows that calved >545 d from the parity 
median (n = 113,052 lactations from 17,336 cows).
Mortality Trait Definition
Four nulliparous mortality traits were defined in the 
present study based on animal age and, where possible, 
a cow mortality trait was defined for each cow-parity 
separately for cows in their first to fifth parity, inclusive; 
the definition of mortality traits have been described in 
detail by Ring et al. (2018). Briefly, a nulliparous ani-
mal’s first year of life was segregated into 4 age groups, 
namely 0 to 2 d of age, 3 to 30 d of age, 31 to 182 d 
of age, and 183 to 365 d of age. An animal that died 
during an age group was defined as dead (i.e., 1) in that 
respective age group, whereas an animal that survived 
the entire duration of an age group was defined as alive 
(i.e., 0) in that age group; animals recorded as alive on 
December 31, 2015, that had not yet reached the final 
day of an age group were not considered in the respec-
tive age group. For cow mortality traits, a cow that 
reached parity i + 1 was assumed not to have died in 
parity i (i.e., 0), whereas a cow that died immediately 
before reaching parity i + 1 was assumed to have died 
in that parity (i.e., 1). For computational reasons, nul-
liparous mortality traits were only considered further 
for animals born between 2007 and 2015, inclusive (n = 
48,840,094 records remained from 8,641,002 animals), 
whereas only cow mortality traits were retained for ani-
mals that calved between 2007 and 2015, inclusive (n 
= 4,303,543 records remained from 2,368,514 cows). In 
addition, only herds with at least one registered death 
in a mortality category were considered for that respec-
tive category.
Pedigree
Pedigree information for each animal was traced back 
at least 4 generations, where possible, and founder ani-
mals were assigned a genetic group. Animals sired by a 
beef breed or an unknown sire were not considered 
further. Additionally, nulliparous mortality traits were 
not considered further for animals with an unknown 
maternal grand-sire. Heterosis and recombination loss 
coefficients for each animal were calculated as 
1
1
−
=
∑ sire dami
i
n
i⋅   and 1 2
2 2
1
−
+
=
∑
sire dami i
i
n
,  respectively, 
where sirei and dami were the proportion of breed i in 
the sire and dam, respectively (VanRaden and Sanders, 
2003). Heterosis coefficients were further segregated 
into 1 of 12 categories (i.e., 0.00, 0.01 to 0.09, 0.10 to 
0.19, 0.20 to 0.29, 0.30 to 0.39, 0.40 to 0.49, 0.50 to 
0.59, 0.60 to 0.69, 0.70 to 0.79, 0.80 to 0.89, 0.90 to 
0.99, and 1.00) and recombination loss coefficients were 
segregated into 1 of 4 categories (i.e., 0.00 to 0.09, 0.10 
to 0.29, 0.30 to 0.49, and ≥0.50).
Contemporary Groups
To represent spring-calving herds, which are both 
the predominant enterprise type in Ireland (Berry et 
al., 2013) and are representative of the herds that had 
a BoHV-1 phenotype, only herds that calved at least 
85% of their cows between January and May, inclusive, 
were considered further. In spring-calving herds, ani-
mals that are either born or calve in close proximity 
to each other are typically managed uniformly; as a 
result, contemporary groups were defined in the present 
study for each herd separately and for each trait sepa-
rately using methods described by Berry et al. (2013). 
Briefly, an algorithm was applied to the data to cluster 
animals together within a herd that were either born 
or calved within 10 d of each other; where 10 animals 
were not initially clustered together, the group was 
amalgamated with an adjacent group. This process was 
reiterated until the contemporary group contained a 
minimum of 10 animals, provided the interval between 
the initial and final event (i.e., calving or birth) did 
not exceed 100 d. Nulliparous animals were assigned a 
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contemporary group based on their birthdate. With the 
exception of CALV42 and AFC in primiparous cows, 
pluriparous cows were assigned a contemporary group 
based on their calving date; primiparous cows were as-
signed a contemporary group for CALV42 and AFC 
based on their birthdate. Contemporary groups with 
<5 animals were discarded.
A random sample of contemporary groups were cho-
sen within each milk production performance, fertility 
performance, and mortality trait separately where at 
least 85% of animals in a contemporary group were 
sired by an animal that also sired at least one animal 
in the BoHV-1 data set. This edit was imposed for 
computational reasons to reduce the number of records 
per trait to (where possible) approximately 100,000. 
The total number of records available per trait in the 
final data set is in Table 1 and Supplemental Table S1 
(https:// doi .org/ 10 .3168/ jds .2018 -14481). The number 
of records that had both a BoHV-1 test result and 
either a milk performance trait, fertility performance 
trait, or a mortality record are in Supplemental Table 
S1 (https:// doi .org/ 10 .3168/ jds .2018 -14481).
Statistical Analyses
Variance components for BoHV-1 were estimated in 2 
separate analyses; the first considered animals exposed 
to BoHV-1 based on the relaxed definition whereas the 
second considered animals exposed to BoHV-1 based on 
the strict definition. Both analyses considered BoHV-1 
as either a binary trait or separately as a continuous 
trait, and variance components for nonvaccinated (i.e., 
gB test kit) and vaccinated (i.e., gE test kit) animals 
were estimated separately using univariate animal lin-
ear mixed models in ASReml (Gilmour et al., 2009). 
Vaccinated and nonvaccinated animals were also ana-
lyzed together where BoHV-1 was considered only as a 
binary trait. Genetic correlations for BoHV-1 measured 
in both vaccinated and nonvaccinated animals were 
estimated using bivariate animal linear mixed models 
in ASReml (Gilmour et al., 2009).
Irrespective of whether the analysis from the re-
laxed exposure definition or strict exposure definition 
was considered, the resulting variance components for 
BoHV-1 were similar in both univariate analyses. As a 
result, only animals deemed exposed to BoHV-1 based 
on the relaxed definition were considered for all bivari-
ate analyses with milk performance traits, fertility per-
formance traits, and animal mortality traits. Genetic 
correlations between BoHV-1 and milk performance 
traits, between BoHV-1 and fertility performance 
traits, as well as between BoHV-1 and cow mortal-
ity traits, were estimated using bivariate repeatability 
animal linear mixed models in ASReml (Gilmour et 
al., 2009); bivariate analyses between BoHV-1 and the 
nulliparous mortality traits were analyzed using animal 
linear mixed models (i.e., no repeatability effect). The 
fitted models were
 
BoHV-1 = CG + het + rec + test age|parity 
+ test date|test kit + a + e,
 
 
Perf = CG + het + rec + calve age|parity + a 
+ PE + e,
a  
 Perf = CG + het + rec + a + e,b  
 
Perf = CG + het + rec + CFS|CFS + calve age|parity 
+ a + P
c
E + e,
 
Mort CG + het + rec + het  + rec + sex 
+ calve ag
null dam dam=
e|parity + d + a + e,dam
 
 
Mort = CG + het + rec + sex + calve age|parity 
+ a
cow progeny
 + PE e,+
where BoHV-1 = BoHV-1 test result (i.e., binary and 
continuous traits); Perfa = milk performance traits of 
milk kilograms, fat kilograms, protein kilograms, fat 
percent, protein percent, fat to protein ratio, and SCS 
Table 1. Number of animals (n), mean prevalence (%), genetic SD (σg), and heritability estimates (h
2; SE in 
parentheses) for antibody response to bovine herpesvirus-1 (BoHV-1) where animals were deemed exposed to 
BoHV-1 based on the relaxed and strict exposure definitions
BoHV-1 trait
Relaxed exposure definition
 
Strict exposure definition
n % σg h
2 n % σg h
2
Vaccinated          
 Binary 4,600 31 0.11 0.12 (0.031)  3,842 38 0.12 0.13 (0.036)
 Continuous 4,600 — 0.29 0.14 (0.034)  3,842 — 0.32 0.16 (0.039)
Nonvaccinated          
 Binary 2,568 41 0.10 0.14 (0.046)  2,027 52 0.10 0.12 (0.051)
 Continuous 2,568 — 0.22 0.15 (0.048)  2,027 — 0.22 0.12 (0.052)
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as well as fertility performance traits of CALV42, CIV, 
CFS, SR21, NSV, CCI, FSC, PR42, and SURV; Perfb 
= fertility trait of AFC; Perfc = fertility trait of PRFS; 
Mortnull = nulliparous mortality traits; Mortcow = cow 
mortality traits; CG = fixed effect of contemporary 
group; het = fixed effect of animal’s heterosis coeffi-
cient; hetdam = fixed effect of animal’s dam heterosis 
coefficient; rec = fixed effect of animal’s recombination 
loss coefficient; recdam = fixed effect of animal’s dam 
recombination loss coefficient; CFS|CFS = fixed qua-
dratic effect of the fertility trait CFS; sex = fixed effect 
of animal’s sex; sexprogeny = fixed effect of sex of animal’s 
progeny; test age|parity = fixed effect of the interaction 
between an animal’s age in months relative to the par-
ity median at sample collection by the animal’s parity 
(i.e., 0, 1, 2, 3, 4, 5); test date|test kit = fixed effect of 
the interaction between an animal’s sample date and 
the test kit used (i.e., gE or gB kit); calve age|parity 
= fixed effect of the interaction between an animal’s 
parity (i.e., 0, 1, 2, 3, 4, 5) and age in months relative 
to the parity median at calving; calve age|paritydam = 
fixed effect of the interaction between the parity of an 
animal’s dam (i.e., 0, 1, 2, 3, 4, 5) and the dam’s age (in 
mo) relative to the parity median when the animal was 
born; a = random additive genetic effect of the animal, 
where a ~N(0, Aσ2a) with σ
2
a representing the additive 
genetic variance of the animal and A the additive ge-
netic relationship matrix among animals; PE = random 
effect of the animal’s permanent environment, where 
PE ~N(0, Iσ2PE) with σ
2
PE representing the permanent 
environmental variance and I the identity matrix; d 
= random additive genetic effect of the animal’s dam, 
where d ~N(0, Aσ2d) with σ
2
d representing the addi-
tive genetic variance for the maternal component; e = 
random residual effect, where e ~N(0, Iσ2e) with σ
2
e 
representing the residual variance.
RESULTS AND DISCUSSION
Descriptive Statistics and Fixed Effects for BoHV-1
Prior to the applied edits, the mean apparent preva-
lence of positive antibody response to BoHV-1 was 
higher for nonvaccinated animals (30%) than for vac-
cinated animals (22%), with 86% of herds having at 
least one animal that had a positive antibody response 
to BoHV-1; the mean apparent prevalence of posi-
tive antibody response to BoHV-1 following edits are 
in Table 1. As cow parity increased, so did the mean 
apparent prevalence of positive antibody response to 
BoHV-1 in both vaccinated and nonvaccinated herds 
(Figure 1). Therefore, it was not surprising that both 
the main effects of parity number and age relative to 
the parity median at BoHV-1 test-date together with 
their interaction were associated (P < 0.001) with an-
tibody response to BoHV-1 (i.e., both the binary and 
continuous BoHV-1 traits) in the present study. Con-
sidering both vaccinated and nonvaccinated animals 
together as a binary trait, relative to a first parity cow, 
the likelihood of a second, third, fourth, and fifth parity 
cow yielding a positive antibody response to BoHV-1 
was 1.05 (95% CI: 1.02 to 1.07), 1.16 (95% CI: 1.14 
to 1.19), 1.22 (95% CI: 1.19 to 1.25), and 1.31 (95% 
CI: 1.27 to 1.35), respectively. Although the associa-
tion between antibody response to BoHV-1 and parity 
number differed by animal age relative to the parity 
median (P < 0.001), the general trend by parity and 
by age was the same (i.e., animals tended to be more 
likely to yield a positive antibody response to BoHV-1 
when they were older and as parity number increased). 
Neither the heterosis coefficient nor the recombination 
loss coefficient was associated (P > 0.05) with antibody 
response to BoHV-1. Both the overall apparent BoHV-
1 prevalence, when considering vaccinated animals and 
nonvaccinated animals together, and the higher ap-
parent BoHV-1 prevalence for nonvaccinated animals 
relative to vaccinated animals in the present study, are 
consistent with previous BoHV-1 prevalence estimates 
in cows (O’Grady et al., 2008; Cowley et al., 2011; Say-
ers et al., 2015). For example, earlier Irish studies have 
reported that between 73 to 80% of beef (O'Grady et 
al., 2008) and dairy (Cowley et al., 2011; Sayers et al., 
2015) herds comprise at least one animal that yields a 
positive antibody response to BoHV-1.
Figure 1. Mean apparent prevalence of bovine herpesvirus-1 
(BoHV-1) antibody positive test results per parity in vaccinated 
(bars) and nonvaccinated (lines) animals that were deemed exposed 
to BoHV-1 based on the relaxed (filled) and strict (no fill) exposure 
definitions.
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A possible indicator of underlying genetic variability 
for antibody response to BoHV-1 is captured in Fig-
ure 2, which illustrates the distribution of the mean 
daughter prevalence of BoHV-1 from sires that had at 
least 25 daughters, deemed exposed to BoHV-1, in at 
least 5 contemporary groups in the present study. One 
sire produced 46 daughters deemed exposed to BoHV-1 
(mean parity = 3.40) in 20 herds, of which 74% of 
his daughters yielded a positive antibody response to 
BoHV-1. Another sire produced 37 daughters (mean 
parity = 3.50), also deemed exposed to BoHV-1, in 4 
herds where only 16% of his daughters yielded a posi-
tive antibody response to BoHV-1. Although, to our 
knowledge, others have not reported variation in the 
mean prevalence of viral diseases among the progeny 
of individual sires, variability in the prevalence of both 
viral and bacterial diseases has been documented else-
where between breeds (Muggli-Cockett et al., 1992; 
Snowder et al., 2005; Richardson et al., 2014). For 
example, Richardson et al. (2014) estimated breeding 
values in Irish cattle for susceptibility to bovine tu-
berculosis; they concluded that Simmental, Charolais, 
and Belgian Blue breeds were considerably more likely 
to succumb to bovine tuberculosis than the Holstein-
Friesian or Aberdeen Angus breeds.
Variance Components
Irrespective of whether a binary or a continuous 
BoHV-1 dependent variable was considered, the esti-
mated variance components for antibody response to 
BoHV-1 were similar for the relaxed and strict exposure 
definitions (Table 1); the estimated direct heritability 
estimates for antibody response to BoHV-1 ranged 
from 0.12 (SE = 0.031) to 0.16 (SE = 0.039). The cor-
responding genetic standard deviation for the binary 
BoHV-1 traits ranged from 0.10 to 0.12 units. Where 
vaccinated and nonvaccinated BoHV-1 test results were 
considered in the same analysis, only as a binary trait, 
heritability estimates for antibody response to BoHV-1 
for the relaxed and strict definitions were 0.09 (SE = 
0.023) and 0.12 (SE = 0.028), respectively.
Although the present study did not have informa-
tion pertaining to the type of vaccination used per 
herd (i.e., live or inactivated vaccine), differences in the 
genetic variability to BoHV-1 may exist among animals 
that received a live vaccine compared with an inacti-
vated vaccine. Estimation of the genetic parameters for 
BoHV-1 for each vaccination type separately could pro-
vide a more useful insight into breeding for resistance 
to BoHV-1. To our knowledge, no heritability estimates 
for antibody response to BoHV-1 are available in the 
literature, nonetheless variance components estimated 
in the present study are similar to estimates for clinical 
signs of BRD in US and Norwegian cattle populations. 
For instance, Snowder et al. (2006) reported a direct 
heritability estimate of 0.08 for BRD in feedlot beef 
calves (n = 18,122) in the US Meat Animal Research 
Center over the years 1987 to 2001. Heringstad et al. 
(2008) also documented a heritability estimate for 
BRD, which they noted was unlikely to be caused by 
IBR infection, of 0.05 in Norwegian Red calves (n = 
250,212). More recently, Schneider et al. (2010) report-
ed a heritability estimate for BRD of 0.11 in preweaned 
US calves (n = 1,519) and 0.07 in a population of US 
feedlot cattle (n = 3,277); the standard errors of the 
Figure 2. Distribution of mean prevalence of bovine herpesvirus-1 (BoHV-1) antibody positive test results in the daughters of sires that 
produced at least 25 daughters in at least 5 contemporary groups where daughters were deemed exposed to BoHV-1 based on the relaxed (filled) 
and strict (no fill) exposure definitions.
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estimates were, however, large (0.04 to 0.06) relative to 
the heritability estimate itself. Nevertheless, the present 
study is the first to elucidate that genetic selection of 
animals for antibody response to BoHV-1 is possible. In 
addition, the extent of genetic gain following selection 
for antibody response to BoHV-1 has the potential to 
be similar for both vaccinated and nonvaccinated ani-
mals (i.e., the genetic standard deviation of the binary 
BoHV-1 trait was similar for vaccinated animals and 
nonvaccinated animals; Table 1), and the number of 
records required to achieve high reliability (estimated 
breeding values) are also similar for both BoHV-1 traits. 
In a single-trait selection index, the incidence of ani-
mals yielding a positive antibody response to BoHV-1 
following exposure to the pathogen could be reduced by 
1.6% per year (with an index reliability of 70% assum-
ing a genetic standard deviation gain of 0.09 units) in 
a well-designed breeding program; this rate of genetic 
gain could be achieved with 100 progeny records per 
sire that have been exposed to BoHV-1. Nonetheless, 
this rate of genetic gain does not consider differences 
in disease dynamics such as genetic variation in host 
infectivity (i.e., some individuals may have a stronger 
ability to transmit infection than others; Anacleto et 
al., 2015), possible differences in the pathogenicity of 
viral strains (Kaashoek et al., 1996), or the potential 
lack of availability of data from animals that have been 
exposed to BoHV-1 where the number of herds that 
choose to vaccinate for BoHV-1 increases. Woolhouse 
et al. (2005) estimated that just 20% of cattle herds are 
responsible for transmitting 80% of infectious diseases, 
which indicates that the rate of disease infectivity is 
not equal among individuals. The phenomenon of “su-
per-spreaders” has important implications for breeding 
programs; genetic selection against “super-spreaders” 
has the potential to minimize the generation of new 
BoHV-1 infections. Recent statistical models that ac-
count for the dynamic nature of infections (Anacleto et 
al., 2015) could be used to estimate genetic parameters 
for infectivity of BoHV-1, provided data were available 
pertaining to (1) animal contact rate, (2) duration of 
the infectious period, and (3) the ability of the host 
to transmit infection (Lipschutz-Powell et al., 2014). 
Further research on the genetic variability of BoHV-1 
could focus on possible genetic variability in infectivity 
of BoHV-1 among cattle. Differences in the expression 
of clinical signs, the quantity of virus shed, and the 
timing of virus shedding relative to inoculation have 
also been reported in calves experimentally infected 
with varying strains of BoHV-1 (Kaashoek et al., 1996; 
Spilki et al., 2004). Results from Kaashoek et al. (1996) 
and Spilki et al. (2004) indicate that genetic variation 
in the humoral immune response to BoHV-1 may differ 
between BoHV-1 strains; the present study, however, 
did not have information pertaining to viral strain.
Concerns have been expressed by some (e.g., Stear 
et al., 2001) that breeding for immune response or 
disease resistance (e.g., selection of animals for a 
negative antibody response to BoHV-1) may lead to 
reduced immune competence. Nevertheless, following 
BoHV-1 infection, animals can never clear the virus 
and they have the ability to repeatedly re-synthesize 
and re-excrete BoHV-1 (Muylkens et al., 2007); thus, 
antibody-positive animals must be considered BoHV-1 
infected (World Organisation for Animal Health, 2010).
Possible Mechanisms for Genetic Variation
Successful BoHV-1 infection in cattle depends upon 
attachment, binding, and penetration of the virus into 
the cells of cattle (Muylkens et al., 2007), followed by 
replication and viral export. Potential defense mecha-
nisms of cattle against BoHV-1 infection, which may 
be (partly) under genetic control, include avoidance of 
(animate and inanimate) infected objects (Medzhitov 
et al., 2012), natural barriers of the skin including 
hair and mucous membranes (Ackermann et al., 2010; 
Biswas et al., 2013), coughing and sneezing (Levings 
and Roth, 2013), variation in the length of the tracheo-
bronchial tree (Ackermann et al., 2010), and antimicro-
bial properties of the innate immune system (Barber, 
2001; Levings and Roth, 2013). Avoidance of BoHV-1 
may function by the animal detecting BoHV-1 in the 
environment, which results in the animal changing its 
own behavior (Hart, 1990; Medzhitov et al., 2012); 
such a phenomenon has been documented in rodents 
(Ehman and Scott, 2001). For example, Ehman and 
Scott (2001) reported that female mice were capable of 
discriminating between males that were infected with 
macroparasites from noninfected males; moreover, the 
female mice tended to preference the uninfected males 
as mating partners. It may be possible that, much like 
the mice (Ehman and Scott, 2001), cattle may be able 
to detect BoHV-1 shedders, thus resulting in a change 
of behavior to avoid BoHV-1 infection. If the animal 
does not alter its behavior sufficiently to avoid BoHV-
1, external barriers of the animal can play a role in 
reducing infection. For instance, the general route of 
entry for BoHV-1 is via the upper respiratory tract 
(Muylkens et al., 2007); nostril hairs in the respiratory 
tract of cattle can provide a physical barrier to the 
inhalation of pathogens (Ackermann et al., 2010) and 
the combination of mucus and cilia functions (known 
as mucociliary clearance) can assist with the removal of 
inhaled particles (Ackermann et al., 2010). In humans, 
suboptimal mucociliary clearance has been documented 
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in patients that suffer from chronic rhinosinusitis but 
not in control patients (Hamilos and Baroody, 2007). In 
addition, genetic variation in genes that contribute to 
the regulation of mucociliary clearance has been associ-
ated with chronic rhinosinusitis in humans (Purkey et 
al., 2014); it may be possible that genetic variation also 
exists in cattle for mucociliary clearance. Furthermore, 
Beecher et al. (2014) documented variability among 
3 dairy genotypes in the body mass components of 
slaughtered cows; they noted that on a per unit of BW 
basis, Holstein-Friesian cows had, on average, a lighter 
heart, lungs, pancreas, reticulorumen, and omasum 
than Jersey cows (P < 0.05). These findings support 
the notion that differences among animals may exist in 
the length of the tracheobronchial tree. A longer tra-
cheobronchial tree, but in particular a longer trachea, 
may reduce the likelihood of pulmonary infection by 
increasing the distance required for pathogens to travel 
from the point of entry through the upper respiratory 
tract (Ackermann et al., 2010); the increased transit 
time and surface area may facilitate a greater period 
of exposure to the innate immune system, helping to 
destroy the pathogens or at least minimize their effects.
Correlations Between BoHV-1 for Vaccinated  
and Nonvaccinated Animals
For both exposure definitions used in the present 
study (i.e., the relaxed and strict exposure definitions), 
the genetic correlations between BoHV-1 in vaccinated 
and nonvaccinated animals were weak (i.e., ranging 
from −0.15 to 0.33) and not different from zero (P > 
0.05), irrespective of whether the dependent variable 
was a binary or a continuous trait. The genetic correla-
tions between vaccinated and nonvaccinated animals 
for antibody response to BoHV-1 as a binary trait were 
−0.15 (SE = 0.308) and 0.10 (SE = 0.270) based on 
the relaxed and strict definitions, respectively; where 
BoHV-1 was considered as a continuous trait, the 
genetic correlations between vaccinated and nonvac-
cinated animals were 0.07 (SE = 0.322) and 0.33 (SE 
= 0.274) for the relaxed and strict definitions, respec-
tively. Although the standard errors were large, results 
from the present study suggest that the humoral im-
mune response to BoHV-1 may differ depending upon 
vaccination status.
In a review of the literature on IBR, Muylkens et al. 
(2007) explains that when a nonvaccinated animal is 
exposed and infected with BoHV-1 for the very first 
time, that animal responds with nonspecific inflam-
matory and cellular reactions. After several days, the 
animal develops humoral and cell-mediated immune 
responses that inhibit the transmission of BoHV-1 to 
other animals (Engels and Ackermann, 1996). The pur-
pose of vaccination is to generate immune “memory” 
cells that will activate immediately upon an initial en-
counter with the BoHV-1 antigen, without the animal 
ever having been exposed to wild-type BoHV-1. That 
“memory” enables the vaccinated animal to mount a 
more rapid and robust immune response (than the 
unvaccinated animal) should the animal ever become 
naturally infected with BoHV-1 (Sjaastad et al., 2010). 
Theoretically, if the animal can generate a faster im-
mune response, the animal should have some ability 
to prevent infection. As a result, vaccinated animals 
should be able to accelerate through some of the criti-
cal immune response steps when exposed to wild-type 
BoHV-1 for the first time compared with the response of 
nonvaccinated animals. Therefore, it may be plausible 
that a hypothetical nonvaccinated animal is genetically 
less likely to produce a positive antibody response to 
BoHV-1 because it has the ability to produce a very 
large quantity of natural killer cells (i.e., kills virus-
infected cells) or interferon type 1 (i.e., inhibits virus 
replication) at a rapid pace. In contrast, a different 
nonvaccinated animal may be genetically more likely 
to produce a positive antibody response to BoHV-1 
when exposed to the pathogen because it is slower at 
producing natural killer cells or interferon type 1. That 
said, if both these animals were vaccinated before ini-
tial exposure to wild-type BoHV-1, their genetic ability 
to withstand infection may alternate. For example, the 
“memory” cells of the first animal may have a poorer 
recognition ability than the second animal, meaning 
that the first animal would be genetically more likely to 
produce a positive antibody response to BoHV-1 than 
the second animal.
Results from the present study suggest that the re-
gions of the bovine genome that influence susceptibility 
to BoHV-1 may differ according to vaccination status 
(i.e., near-zero genetic correlations were estimated 
between BoHV-1 for vaccinated and nonvaccinated 
animals). Nonetheless, results from the present study 
(discussed herein) also indicate similar genetic correla-
tions between performance traits with BoHV-1 in both 
vaccinated and nonvaccinated animals. That does not, 
however, suggest that identical regions of the genome 
govern differences in humoral immune response to 
BoHV-1 in both vaccinated and nonvaccinated ani-
mals. This is because performance traits, such as milk 
and fertility, are complex traits that are controlled by 
a large number of genes, each with a very small ef-
fect (Garrick and Fernando, 2015). Further research on 
the genomic regions associated with humoral immune 
response to BoHV-1 in both vaccinated and nonvac-
cinated animals could provide more insight into this.
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BoHV-1 and Milk Performance
To our knowledge, no estimates exist on the genetic 
inter-relationships between milk performance traits 
and the humoral immune response to viral diseases in 
cattle. The present study suggests that genetic selec-
tion for milk yield or milk constituents likely has little 
or no effect on whether the animal yields a positive 
or negative antibody response to BoHV-1, and vice 
versa. Irrespective of whether vaccinated or nonvacci-
nated animals were considered, the genetic correlations 
between 305-d milk performance traits and antibody 
response to BoHV-1, considered as either a binary or a 
continuous trait, were weak and not different from zero 
(P > 0.05). The genetic correlations between BoHV-1 
and all the milk performance traits ranged from −0.13 
(SE = 0.099) to 0.17 (SE = 0.096). No difference ex-
isted between the genetic correlations of BoHV-1 with 
milk performance traits, irrespective of the BoHV-1 
trait investigated, and thus only results for the com-
bined BoHV-1 trait are presented (i.e., vaccinated and 
nonvaccinated animals considered as a binary trait) 
in Table 2. The genetic correlations between the milk 
production traits and antibody response to BoHV-1 
estimated in the present study support the near-zero 
genetic correlations documented elsewhere between 
clinical signs of BRD and other performance traits in 
cattle. For example, excluding bone yield, Snowder et 
al. (2007), using data from feedlot beef cattle, estimated 
genetic correlations between BRD with growth, car-
cass, and meat palatability traits ranging from −0.16 
to 0.20, albeit with large standard errors (0.07 to 0.17); 
this indicates that genetic selection for growth, carcass, 
or meat palatability traits is likely to have no effect on 
genetic predisposition to BRD.
Phenotypic correlations in the present study between 
BoHV-1 and 305-d milk performance traits ranged from 
−0.04 (SE = 0.017) to 0.05 (SE = 0.023). Phenotypic 
studies elsewhere in dairy cattle (Hage et al., 1998; van 
Schaik et al., 1999) on performance losses arising from 
BoHV-1 documented a reduction in dairy cow milk 
yield of 0.92 to 9.52 L per infected cow during the pe-
riod immediately following infection, for a short period. 
Based on bulk-tank milk samples, Sayers (2017) docu-
mented a reduction in 305-d milk yield in Irish herds 
that yielded a positive antibody response to BoHV-1; 
nevertheless, Sayers (2017) noted that the reduction in 
herd milk yield was likely a consequence of the creation 
of new BoHV-1 infections within the herd rather than a 
persistent loss of milk production among cows infected 
with BoHV-1 over a longer period. In the Netherlands, 
Hage et al. (1998) estimated a reduction in milk yield of 
9.5 L/d in cows that were newly infected with BoHV-1 
over a 14-d period following an induced BoHV-1 out-
break. During the infectious period, Hage et al. (1998) 
observed no increase in clinical mastitis prevalence, no 
change in mean fat or protein concentration and no 
increase in SCC. Results from these studies (Hage et 
al., 1998; van Schaik et al., 1999; Sayers, 2017) suggest 
that while a reduction in milk yield is often observed in 
cows that become infected with BoHV-1, the duration 
of the affected period and the associated reduction in 
milk performance is short-lived.
BoHV-1 and Fertility Performance
Even though the standard errors were generally large, 
a consistent trend was observed that animals genetically 
predisposed to yielding a positive antibody response to 
BoHV-1 were more likely to have suboptimal fertility; 
the conclusion was irrespective of the BoHV-1 trait 
considered and as a result only correlations between 
the combined BoHV-1 trait and fertility performance 
traits are presented (Table 3). To our knowledge, no 
associations are documented between animal genetic 
predisposition to IBR infection (or other respiratory 
infections) and fertility performance in cattle; on the 
other hand, the documented phenotypic associations 
between IBR infection and fertility performance are 
generally unfavorable (Graham, 2013). In Croatia, for 
example, Biuk-Rudan et al. (1999) noted that 69% of 
Holstein-Friesian cows which tested positive for IBR 
Table 2. Mean, genetic SD (σg), direct h
2 estimates (SE in parentheses), as well as the genetic correlations (rg; 
SE in parentheses) among 305-d milk performance traits with antibody response to bovine herpesvirus-1 where 
vaccinated and nonvaccinated animals were considered as the same (binary) trait
Trait Mean σg h
2 rg
Milk, kg 6,154 451.24 0.33 (0.011) 0.06 (0.073)
Fat, kg 255 17.01 0.29 (0.011) 0.04 (0.074)
Protein, kg 220 13.14 0.27 (0.011) 0.04 (0.077)
Fat, % 4.18 0.32 0.62 (0.010) −0.01 (0.056)
Protein, % 3.58 0.16 0.66 (0.009) 0.01 (0.056)
Fat:protein ratio 1.17 0.07 0.44 (0.010) −0.01 (0.064)
Loge(SCC/1,000) 4.43 0.22 0.10 (0.008) −0.12 (0.099)
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had reproductive disorders (e.g., repeat breeding and 
cystic ovaries), whereas only 31% of their contempo-
raries that tested negative for IBR had reproductive 
disorders. In a separate study, Raaperi et al. (2012) 
reported that cows residing in Estonian herds with a 
BoHV-1 prevalence ranging from 1 to 49% had a 7.3 
times greater odds of aborting (95% CI: 2.0 to 26.9) 
during gestation and a 5.2 times greater odds of requir-
ing more inseminations per pregnancy (95% CI: 1.5 to 
18.4) than cows residing in herds with a 0% BoHV-1 
prevalence. The phenotypic associations between IBR 
and fertility estimated in previous studies support find-
ings in the present study for a tendency of animals 
genetically more likely to have inferior fertility also to 
be genetically more likely to yield a positive antibody 
response to BoHV-1.
BoHV-1 and Mortality
Even though the genetic correlations between anti-
body response to BoHV-1 and mortality in the present 
study were not different from zero (P > 0.05), results 
from the present study suggest that animals whose 
progeny were genetically predisposed to yielding a 
positive antibody response to BoHV-1 also had prog-
eny that were more likely to die >6 mo of age (Table 
4). Consistent with the genetic correlations between 
BoHV-1 and the performance traits of milk and fertil-
ity, differences in the genetic correlations among the 
5 BoHV-1 traits did not exist; therefore, only results 
for the combined BoHV-1 trait are presented (i.e., 
vaccinated and nonvaccinated animals considered as a 
binary trait) in Table 4.
Respiratory infection (including infection with 
BoHV-1) is the most commonly diagnosed cause of 
mortality, accounting for 21% of deaths, in both young 
and mature cattle submitted for postmortem examina-
tion to Irish veterinary laboratories (AFBI and DAFM, 
2016). Therefore, it is not surprising that the present 
study identified an unfavorable genetic relationship be-
tween antibody response to BoHV-1 and mortality. In 
previous studies, Snowder et al. (2005, 2006) reported 
breed differences in the incidence of beef calf mortality 
following diagnosis with BRD infection. For example, 
Snowder et al. (2005) noted that Simmental (i.e., 18%), 
MARC III (i.e., a composite beef breed; 17%), and Red 
Poll (i.e., 16%) breeds had the highest mortality rate 
of calves diagnosed with BRD (n = 4,199), whereas 
the lowest mortality rate was in Limousin (i.e., 7%) 
and Braunvieh (i.e., 9%) breeds. Interestingly, the vari-
ability in calf mortality among breeds was not a func-
tion of the breed proportion diagnosed with BRD, as 
Table 3. Mean (or median where appropriate), genetic SD (σg), direct h
2 estimates (SE in parentheses), as well as the genetic correlations (rg; 
SE in parentheses) between fertility performance traits with antibody response to bovine herpesvirus-1 where vaccinated and nonvaccinated 
animals were considered as the same (binary) trait
Trait Mean σg h
2 rg
Age at first calving,1 d 737 7.23 0.011 (0.003) 0.05 (0.193)
Calved within 42 d of calving season, proportion 0.76 0.03 0.011 (0.003) −0.24 (0.169)
Calving interval,1 d 369 5.07 0.011 (0.003) 0.26 (0.182)
Calving to first service interval, d 76 2.57 0.034 (0.005) −0.29 (0.134)
Submission rate ≤21 d of start of breeding season, proportion 0.77 0.06 0.024 (0.004) −0.06 (0.142)
No. of services 1.54 0.09 0.014 (0.003) 0.22 (0.147)
CCI,1 d 86 2.17 0.008 (0.002) 0.12 (0.173)
First service to conception interval, d 13 1.83 0.004 (0.002) 0.39 (0.205)
Pregnant to first service, proportion 0.54 0.05 0.009 (0.004) −0.20 (0.168)
Pregnant within 42 d of breeding season, proportion 0.74 0.05 0.015 (0.003) −0.10 (0.160)
Survival, proportion 0.84 0.04 0.015 (0.003) −0.06 (0.155)
1Calving to conception interval, median presented instead of mean.
Table 4. Mean, genetic SD (σg), direct heritability estimates (h
2
direct; SE in parentheses), maternal heritability estimates (h
2
maternal; SE in 
parentheses), as well as the genetic correlations (rg; SE in parentheses) among animal mortality traits and antibody response to bovine 
herpesvirus-1 where vaccinated and nonvaccinated animals were considered as the same (binary) trait
Trait Mean σg h
2
direct h
2
maternal rg
Death 0 to 2 d of age, % 2.58 0.010 0.0038 (0.0016) 0.0071 (0.0019) 0.08 (0.251)
Death 3 to 30 d of age, % 2.44 0.012 0.0060 (0.0019) 0.0010 (0.0010) −0.13 (0.213)
Death 31 to 182 d of age, % 2.54 0.007 0.0022 (0.0012) 0.0005 (0.0008) −0.06 (0.282)
Death 183 to 365 d of age, % 0.85 0.003 0.0008 (0.0009) 0.0000 (0.0000) 0.53 (0.374)
Death during cow lactation, % 2.35 0.015 0.0092 (0.0035) NE1 0.34 (0.200)
1NE = not estimated.
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the Braunvieh breed had the highest incidence of BRD 
(i.e., 19%) yet their mortality rate was lower than the 
average mortality rate of all breeds (i.e., 13%).
It has been reported that, in general, death does not 
occur as a direct consequence of infection with BoHV-
1 itself per se, but that death often occurs following 
secondary infections that arise due to BoHV-1 infec-
tion (Yates, 1982). It may be possible that animals 
genetically predisposed to yielding a positive antibody 
response to BoHV-1 are also animals that tend to have 
suboptimal immune function, making them predis-
posed to infection with several pathogens, which subse-
quently increases their likelihood of dying. Heritability 
estimates (that range from 0.16 to 0.41) have been 
reported for immune response traits in Canadian dairy 
cows (Thompson-Crispi et al., 2012). Results from the 
present study support previous findings that genetic 
selection for a negative antibody response to BoHV-1 
may help in reducing the incidence of animal mortality.
CONCLUSIONS
Breeding for animals that are resistant to BoHV-1 
infection (i.e., a negative antibody response) could pro-
vide producers with an additional method to reduce the 
incidence of IBR or even potentially realize the addi-
tional EU intra-community trade guarantees available 
to countries that are either free from IBR or have an 
approved eradication program. Results from the present 
study substantiate that ample genetic variation exists 
for antibody response to BoHV-1; therefore, consider-
able genetic gains could be made. Moreover, results 
from the present study imply that selection for animals 
that are resistant to BoHV-1 infection would not have 
ramifications for genetic selection for milk production 
traits (other than an effect on selection intensity), 
whereas it may be beneficial in improving animal fertil-
ity and possibly even reducing the incidence of animal 
mortality.
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